An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome
Clinical trial NCT01818921 · COMPLETED
Trial details
- NCT number
- NCT01818921
- Sponsor
- Zafgen, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2013-11-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.